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To our knowledge, no reliable clinical prediction rule (CPR) for identifying bacteremia in
hemodialysis (HD) patients has been established. The aim of this study was to develop a
CPR for bacteremia in maintenance HD patients visiting the outpatient department.
Methods
This multicenter cohort study involved consecutive maintenance HD patients who visited
the outpatient clinic or emergency room of seven Japanese institutions between August
2011 and July 2013. The outcome measure was bacteremia diagnosed based on the results
of blood cultures. The candidate predictors for bacteremia were extracted through a litera-
ture review. A CPR for bacteremia was developed using a coefficient-based multivariable
logistic regression scoring method, and calibration was performed. The test performance
was then assessed for the CPR.
Results
Of 507 patients eligible for the study, we analyzed the 293 with a complete dataset for candi-
date predictors. Of these 293 patients, 48 (16.4%) were diagnosed with bacteremia. At the
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conclusion of the deviation process, body temperature 38.3˚C, heart rate 125 /min, C-
reactive protein 10 mg/dL, alkaline phosphatase >360 IU/L, and no prior antibiotics use
within the past week were retained and scored. The CPR had a good fit for the model on cal-
ibration. The AUC of the CPR was 0.76, and for score CPR 2, the sensitivity and specific-
ity were 89.6% and 51.4%, respectively.
Conclusions
We established a simple CPR for bacteremia in maintenance HD patients using routinely
obtained clinical information in an outpatient setting. This model may facilitate more appro-
priate clinical decision making.
Introduction
Bacteremia is a common and serious condition worldwide and associated with a high mortality
[1]. This condition is a particularly thorny problem in hemodialysis (HD) patients, since the
morbidity and mortality of bacteremia in this population are extremely high compared to the
general population [2–10]. Therefore, appropriate diagnosis and treatment are of great import
in HD patients, as their outcomes can be quite poor.
Several clinical prediction rules (CPRs) with excellent predictive ability for bacteremia in
the general population have been developed in recent years [11–14]. However, these CPRs
include predictors that are difficult to apply to HD patients, such as serum creatinine, blood
urea nitrogen, and electrolyte concentration, since these variables are known to be greatly
affected by dialysis treatment. To our knowledge, no CPRs for bacteremia in HD patients have
yet been established, a marked unmet need.
Two major differences have been noted with respect to bacteremia infection between main-
tenance HD patients and the general population. First, the incidence of bacteremia is much
higher in maintenance HD patients than in the general population, as mentioned above. Previ-
ous cohort studies have shown that the incidence of bacteremia in maintenance HD patients is
10.40–18.98 per 100 person-years [2–7, 15], which is higher than the incidence of 0.216 per
100 person-years in the general population [1]. Further, the annual mortality due to bacter-
emia in HD patients is 100–300 times that in the general population. Even after adjustment for
age, race, sex, diabetes status, and record errors, the mortality due to bacteremia is still 50
times higher in these patients than in the general population [8–10]. As such, bacteremia is
considered a disease that is both extremely common and associated with serious outcomes in
maintenance HD patients. Second, the pathogen type and etiology of bacteremia in mainte-
nance HD patients differs from those commonly observed in the general population. The most
frequently identified pathogen of bacteremia in the general population is Escherichia coli (E.
coli), accounting for 22%-54% of cases [1, 16–21], with the urinary tract reportedly the most
common route of infection, followed by the respiratory and gastrointestinal tracts [22]. In con-
trast, in maintenance HD patients, the most frequently identified pathogen of bacteremia is
Staphylococcus aureus, accounting for 27%-39% of cases [6, 23, 24], with the most frequent
routes of infection reportedly transdermal and trans-catheter sites.
Despite the substantial differences in the pathology and prognosis of bacteremia between
HD patients and the general population, no CPRs have yet been established specifically target-
ing this at-risk group. In the present study, we developed and validated a new CPR for bacter-
emia specifically for maintenance HD patients.
A Clinical Prediction Rule for Bacteremia among Hemodialysis Patients
PLOS ONE | DOI:10.1371/journal.pone.0169975 January 12, 2017 2 / 12
Materials and Methods
Study Design
We conducted a multicenter retrospective cohort study of maintenance HD patients at six
tertiary-care institutions, all of which receive patients on an emergency basis and all of
which provide primary, secondary, and tertiary care; and one secondary-care institution
that receives patients on an emergency basis and provides both primary and secondary care.
All seven institutions are teaching hospitals. The present study was approved by the ethics
committee of St. Marianna Medical University (No. 2713), and the study was conducted in
accordance with the ethical standards of the Declaration of Helsinki. In the present study,
the Department of Nephrology and Hypertension, St. Marianna University School of Medi-
cine, connected anonymous data from the participating facilities. In addition, since all of the
patient information analyzed in this study was retrospective, the consent of participants was
not obtained.
In the present study, the Department of Nephrology at Chubu Rosai Hospital compiled
anonymous data from the participating facilities. In addition, since all patient information
analyzed in this study was retrospective, participants’ consent was not obtained. The study
results are reported in accordance with the Transparent Reporting of a multivariable predic-
tion model for Individual Prognosis Or Diagnosis (TRIPOD) statement [25].
Participants
The inclusion criteria of the present study were as follows: consecutive HD patients who vis-
ited the outpatient department or emergency room between August 2011 and July 2013 and
had blood drawn for cultures within 48 h from their initial arrival at the hospital. The exclu-
sion criteria of this study were follows: under 18 years old; low frequency of HD (<1 time per
week); combination of peritoneal dialysis; less than 2 weeks from the introduction of HD; and
hospitalized patients referred from another hospital.
Among the participants who met the eligibility criteria, those with a complete dataset for
candidate predictors were assigned to the derivation set. The set for internal validation was
extracted using the bootstrap method.
We estimated that more than 10 cases with the outcome for each potential predictor in a
multivariate model were needed to develop a clinical prediction model, based on common
practice. Since we were attempting to create a CPR consisting of 5 item predictors, 50 out-
comes were estimated to be necessary. The proportion of bacteremia in our study partici-
pants were estimated to 16%, based on the findings of previous Japanese studies conducted
in the general population, which is thought to have a lower proportion of bacteremia than
an HD population. We therefore estimated the required sample size to be a minimum of
320.
Outcome Measures
The primary outcome measure was bacteremia diagnosed is based on the results of blood cul-
tures at the time of the patient‘s visit. The diagnosis of bacteremia was made when any bacteria
not attributed to contamination were detected in a blood culture. Contamination was defined
as follows: cases where only 1 of 2 sets of culture bottles was positive, or cases with detection of
certain species of bacteria, such as diphtheroids, Bacillus sp., Propionibacterium sp., micrococci,
Corynebacterium sp., and coagulase-negative staphylococci. Finally, an external consensus
panel of two physicians well-trained in infectious diseases determined whether a culture was
contaminated or not based on the above definitions and their clinical expertise.
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Candidate Predictors
Exhaustive variables already known to be predictors for bacteremia were selected from CPRs
analyzed in an existing systematic review [11] and extracted by adding a search period through
April 1, 2016, using the same search formula of MEDLINE via PubMed as a systematic review
by Eliakim et al., as follows: ((predict[All Fields] OR predicting[All Fields] OR prediction[All
Fields]) AND (("bacteraemia"[All Fields] OR "bacteremia"[MeSH Terms] OR "bacteremia"[All
Fields]) OR (("blood"[Subheading] OR "blood"[All Fields] OR "blood"[MeSH Terms]) AND
("rivers"[MeSH Terms] OR "rivers"[All Fields] OR "stream"[All Fields]) AND ("infection"[-
MeSH Terms] OR "infection"[All Fields])))) AND ("2014/10/01"[PDAT]: "2016/04/01"[PDAT])
(12–14). The candidate predictors were then selected from among these exhaustive predictors
through consultation with two reviewers, each of whom had more than 10 years’ experience as
nephrologists, based on the predictors’ usefulness in clinical practice in maintenance HD
patients.
The final selected predictors were as follows: age, vital signs at the time of visit (body tem-
perature, systolic blood pressure, pulse rate, percutaneous oxygen saturation, Glasgow Coma
Scale [GCS]), antibiotics use within one week from hospital visit, patient’s complaints (chill,
nausea, focal abdominal signs), and laboratory data at hospital visit (white blood cell [WBC]
count, platelet count, serum albumin, serum alkaline phosphatase [ALP], C-reactive protein
[CRP]).
Specific Predictors for the HD Population
In addition to the candidate predictors, we identified several further predictors for bacteremia
that are specific to the HD population. Variables considered to be related to bacteremia were
selected by referencing the existing literature and conducting multivariate regression with clin-
ical expertise. We then selected those variables readily available in a general clinical setting as
the specific predictors from among the available variables. Ultimately, non-arteriovenous fis-
tula (non-AVF) use as vascular access [26–29] was identified as a predictor specific to HD
patients.
Statistical Analysis
Descriptive statistics. We analyzed the predictors and the outcome as well as other clini-
cal information, including gender, HD vintage, cause of chronic kidney disease (CKD), and
pathogens of bacteremia. Continuous and categorical variables are presented as the median
(quartile) and number (percentage), respectively.
Development of a prediction rule. Among the candidate predictors, the continuous vari-
ables were changed to binary variables based on the cut-off value referenced from previous
studies. All of the candidate predictors were selected through stepwise backward selection with
a p-value<0.05. We then analyzed the cases with complete data available for the selected pre-
dictors via this process.
To establish a CPR from the candidate predictors, a regression coefficient-based scoring
method was used. First, the ratio based on each β-coefficient relative to a reference that was an
intermediate value of the two variables with the smallest β-coefficient was calculated. Then, the
ratio was converted to the appropriate integer. The appropriate integer was chosen from inte-
gers close to the number ensuring the highest predictive ability for bacteremia. The total score
was calculated by summing the scores for each variable.
For further investigation, the modified CPR, developed by adding non-AVF as an HD-spe-
cific predictor for bacteremia to the established CPR, was scored to verify the influence of
these predictors on the predictive ability for bacteremia. Calibration was performed based on
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the Hosmer-Lemeshow chi-square statistic [30] and the slope and intercept of the calibration
plot [31] for the CPR.
Assessment of test performance. To evaluate potential cut-off scores, we computed the
sensitivity, specificity, likelihood ratio, positive predictive value, and negative predictive value
for the CPR.
Validation process. To validate the final model, we used a bootstrapping technique with
200 resamples [32]. The discriminatory ability of the prediction rules was assessed by the area
under the receiver operating characteristic curve. All of the statistical analyses were performed
using Stata version 13.1 (Stata Corp., College Station, TX, USA).
Results
Description of Study Cohort
Among 507 participants with 68 cases of bacteremia who met the eligible study criteria, the
293 participants with 48 cases of bacteremia who had a complete dataset for the candidate pre-
dictors were analyzed, as shown in Fig 1. Table 1 shows the baseline characteristics of the par-
ticipants. Of the 293 participants, the median age was 74 years, 66.6% were men, the most
frequent cause of chronic kidney disease was diabetic nephropathy (42.0%), the most frequent
route of vascular access was arteriovenous fistula (83.6%), the mean HD vintage was 61
months, and 16.4% of patients had taken antibiotics within 1 week prior to hospital visit.
Table 2 shows the pathogens associated with bacteremia in our population. The most fre-
quent pathogen was Staphylococcus aureus, accounting for 39.6% (19 cases) of all bacteremia
cases. Of these cases, 12 were Methicillin-sensitive S. aureus (MSSA), while the other 7 were
Fig 1. Study flow CPR: clinical prediction rule.
doi:10.1371/journal.pone.0169975.g001
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Methicillin-resistant S. aureus (MRSA). Klebsiella pnuemoniae and Escherichia coli accounted
for 9 and 7 cases, respectively. Among 48 cases with bacteremia, 4 were polymicrobial.
CPR
Stepwise backward selection identified body temperature 38.3˚C, pulse rate 125/min,
CRP 10 mg/dL, ALP 360 IU/L, and no antibiotics used within one week before the hospi-
tal visit as potential predictors. Table 3 shows the results of regression coefficient-based scor-
ing. Our CPR ultimately included the above 5 variables with 1 point each (total 5 points). The
Table 1. Baseline characteristics (N = 293).
Median (quartile or %) Median (quartile or %)
Sex Medication
Male 195 (66.6) Steroid use 33 (11.3)
Female 98 (33.5) Immunosuppressant use 5 (1.7)
Age (years) 74 (66, 81) Antibiotics use within 1 week 48 (16.4)
Vital signs Symptoms
Body temperature (˚C) 37.2 (36.6, 38.1) Chill 13 (4.4)
Systolic blood pressure (mmHg) 136 (114, 160) Nausea 28 (9.6)
Heart rate (/min) 84 (74, 100) Focal abdominal sign 29 (9.9)
SpO2 (%) 97 (95, 98) Causes of CKD
(FiO2) 0.21 (0.21, 0.21) Diabetic nephropathy 123 (42.0)
GCS<15 45 (15.4) Hypertensive nephrosclerosis 61 (20.8)
HD vintage (months) 61 (23, 112) Chronic glomerulonephritis 45 (15.4)
Vascular access Others and unknown 64 (21.8)
AV fistula 245 (83.6) Laboratory findings
AV graft 28 (9.6) White blood cell (/μL) 8400 (5900, 11300)
Superficial artery 16 (5.5) Platelet count (/μL) 14.9 (10.5, 20)
Permanent catheter 4 (1.4) Albumin (mg/dL) 3.3 (2.9, 3.6)
History of bacteremia 31 (10.6) Alkaline phosphatase (IU/L) 271 (212, 382)
Comorbidities C-reacted protein (mg/dL) 6.1 (1.8, 12.8)
Diabetes mellitus 131 (44.7) Bacteremia 48 (16.3)
Malignancy 33 (11.3)
SpO2: oxyhemoglobin saturation measured by pulse oximetry, FiO2: fraction of inspiratory oxygen, GCS: Glasgow Coma Scale, HD: hemodialysis, AV
fistula: arteriovenous fistula, CKD: chronic kidney disease
doi:10.1371/journal.pone.0169975.t001
Table 2. Pathogens of bacteremia.
Bacteria N Bacteria N
Staphylococcus aureus 19 Ecterococcus faecalis 1
Methicillin-sensitive Staphylococcus aureus 12 Pseudomonas aerugiosa 1
Methicillin-resistant Staphylococcus aureus 7 Streptococcus salivarius 1
Klebsiella pneumoniae 9 Streptococcus pneumoniae 1
Escherichia coli 7 Streptococcus mutans 1
Coaglase-negative staphylococcus species 5 Parabacteroides distasonis 1
Clostridium perfringens 2 Helicobacter cinaedi 1
Bacteroides 2 Anaerobic gram-negative bacilli 1
Enterococcus faecium 2
doi:10.1371/journal.pone.0169975.t002
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Hosmer-Lemeshow chi-squared statistic for the CPR was 1.99 (p = 0.57), and the calibration
slope (intercept) of the CPR was 0.86 (0.01). The sensitivities, specificities, and likelihood
ration for possible cut-off scores in prediction rule are shown in Table 4. With a value of 2 set
as the cut-off score in the CPR, the sensitivity was 89.6%, the specificity was 51.7%, the positive
likelihood ratio was 1.8, the negative likelihood ratio was 0.2, and the percentage of false nega-
tives was 3.8% (5/131).
Next, as shown in Table 5, the modified CPR including non-AVF as the HD-specific pre-
dictor was scored. The Hosmer-Lemeshow chi-squared statistic for the modified CPR was 2.12
(p = 0.71). The calibration slope and intercept of the CPR were 0.97 and -0.02, respectively.
Internal Validation—CPR
The internal validity of the CPR was verified in the participants extracted via the bootstrap
method. The area under the ROC curve (AUC) of the CPR was 0.76 (95% confidence interval
[CI]: 0.69, 0.82).
Table 3. Multivariate analysis and scoring.
Selected variables Β-coefficient 95% CI p-value Score
Body temperature 38.3˚C 1.12 0.34, 1.91 <0.01 1
Heart rate 125 /min 1.12 0.01, 2.22 0.04 1
CRP 10 mg/dL 1.31 0.60, 2.01 <0.01 1
ALP > 360 IU/L 1.05 0.35, 1.74 <0.01 1
No prior ABx within 1 w 1.3 0.15, 2.45 0.03 1
CRP: C-reactive protein, ALP: alkaline phosphatase, ABx: antibiotics, 95% CI: 95% confidence interval
doi:10.1371/journal.pone.0169975.t003
Table 4. Assessment of test performance.
Cutoff Total Bacteremia Sensitivity (95% CI) Specificity (95% CI) LR+ (95% CI) LR- (95% CI) PPV (95% CI) NPV (95% CI)
1 278 48 100 (92.6, 100) 6.1 (3.5, 9.9) 1.1 (1, 1.1) 0 17.3 (13, 22.2) 100 (78.2, 100)
2 162 43 89.6 (77.3, 96.5) 51.4 (45, 57.8) 1.8 (1.6, 2.2) 0.2 (0.1, 0.5) 26.5 (19.9, 34) 96.2 (91.3, 98.7)
3 54 22 45.8 (31.4, 60.8) 86.9 (82.1, 90.9) 3.5 (2.3, 5.5) 0.6 (0.5, 0.8) 40.7 (27.6, 55) 89.1 (84.5, 92.8)
4 9 5 10.4 (3.5, 22.7) 98.4 (95.9, 99.6) 6.4 (1.8, 22.9) 0.9 (0.8, 1) 55.6 (21.2, 86.3) 84.9 (80.2, 88.8)
5 0 0
LR+: positive likelihood ratio, LR-: negative likelihood ration, PPV: positive predictive value, NPV: negative predictive value, 95% CI: 95% confidence
interval
doi:10.1371/journal.pone.0169975.t004
Table 5. Multivariate analysis and scoring for the modified CPR.
Variables Β-coefficient 95% CI p-value Score
Established CPR + non-AVF Body temperature 38.3˚C 1.12 0.34, 1.91 <0.01 1
Heart rate 125/min 1.12 0.01, 2.22 0.04 1
CRP 10 mg/dL 1.31 0.60, 2.01 <0.01 1
ALP > 360 IU/L 1.05 0.35, 1.74 <0.01 1
No prior ABx within 1 w 1.3 0.15, 2.45 0.03 1
Non-AVF 1.3 0.15, 2.45 0.03 1
CPR: clinical prediction rule, CRP: c-reacted protein, ALP: alkaline phosphatase, ABx: antibiotics, 1 w: one week, AVF: arteriovenous fistula
doi:10.1371/journal.pone.0169975.t005
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Internal Validation—Modified CPRs Adding HD-specific Predictors
The internal validity of the modified CPR adding non-AVF was verified in the participants
extracted via the bootstrap method. The AUC of the modified CPR was 0.74 (95% CI: 0.67,
0.81).
Discussion
In this study, we developed a CPR for bacteremia in maintenance HD patients. Although, pre-
vious studies have already established CPRs for bacteremia in the general population [11–14],
to our knowledge, this is the first prediction rule modified for use in maintenance HD patients.
Of the two CPRs, we determined that the CPR not including non-AVF as an HD-specific pre-
dictor is the more useful of the pair for clinicians for three reasons. First, the CPR without
non-AVF has better diagnostic accuracy with a higher AUC. Second, the study population of
this investigation has a much higher proportion of AVF, which is the most common vascular
access among Japanese HD patients. As such, a CPR with non-AVF might have low generaliz-
ability. Third, a score of2 for the CPR without any HD-specific predictors had high sensitiv-
ity and a negative predictive value. We therefore named this CPR the “BAC-HD” (Body
temperature38.3˚C, Alkaline phosphatase360 IU/L, CRP10 mg/dL, Heart rate125/
min, Drug: no prior ABx use within 1 week) score.
A BAC-HD score2 with high sensitivity can be useful for ensuring that bacteremia infec-
tions, which are a common and serious issue for HD patients, are not missed. Careful observa-
tion can lead to prompt initiation of intravenous antibiotics, which reduces the mortality rate
due to infection in dialysis patients.
The BAC-HD score has two major strengths. First, these criteria are considered suitable for
use in actual clinical settings, since they include routine clinical data. Specifically, the BAC-HD
contains two blood test items—ALP and CRP—that are relatively easy to measure in a Japanese
hospital setting; these items provide are nearly as easy to measure as a Complete Blood Count.
Furthermore, the present CPR is expected to be used in other facilities besides secondary medi-
cal institutions, and the ALP can be measured within 1 h in such facilities. In situations involv-
ing HD patients suspected of having bacteremia, although the body temperature, heart rate,
history of antibiotic use and CRP are evaluated as a rule in general, the addition of ALP mea-
surement may further support making clinical decisions. Second, the criteria are extremely sim-
ple, with only five items, which is few compared with the CPRs for bacteremia in the general
population that mostly have more than 10 items. We believe that the simplicity of the BAC-HD
score may be attributed to the relatively uniform etiology of bacteremia in HD patients com-
pared with the general population. This simplicity should facilitate the detection of bacteremia
in maintenance HD patients and encourage rapid and appropriate decision-making.
In this prediction rule, in addition to the items known to be associated with bacteremia in
the general population, we incorporated non-AVF as an HD patient-specific item, which is
known to be a strong risk factor for blood stream infections in maintenance HD patients [33]
[34, 35]. However, the CPR with non-AVF did not show a superior predictive ability to the
original CPR without non-AVF. We attribute this lack of superiority to the markedly high pro-
portion of AVF vascular access in Japan, in contrast to the situation in the United States [36].
Indeed, even in our cohort, the proportion of AVF was 83.6%, indicating little variation, which
may have diluted the contribution of non-AVF to bacteremia. Given the recent launch of the
“Fistula First” awareness campaign by the National Kidney Foundation to promote the initia-
tion of AVF vascular access in HD induction, we expect AVF access to become mainstream
globally. In this context, our prediction rule is considered to be a suitable model for global HD
patients in the future.
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In the present study, a high ALP level was extracted as an effective predictor. A small obser-
vational study further suggested the close relationship between an extremely high ALP level
and bacteremia [37]. In that study, the authors speculated that the observed extremely high
ALP level was the result of bacteremia-related hepatic dysfunction. ALP is also considered to
have an anti-inflammatory effect, given its dephosphorylating and lipopolysaccharide (LPS)
detoxifying activity [38–40]. However, LPS is produced by gram-negative bacteria; as such,
this etiology for ALP elevation cannot explain the elevation observed in HD patients with bac-
teremia, as the pathogens in this population are typically not gram-negative. Further investiga-
tions will therefore be needed to clarify the detailed etiology of ALP elevation in bacteremia
among HD patients.
Limitations
Several limitations to the present study warrant mention. First, given the relatively large size
and educational function of the facilities used as the study sites, our rule may not be able to be
used at other facilities with different roles in the region. Future studies should conduct external
validation of our rule in different settings. Second, because we used a complete dataset for the
analysis, subjects with a relatively mild clinical presentation without a detailed history or labo-
ratory test findings were excluded. However, since the measured items in this study were not
particularly special and are routinely measured in cases of suspected bacteremia, we believe
that such exclusion did not strongly influence the distribution of the severity and comorbidi-
ties in the study population. Third, because this was a retrospective cohort study, we cannot
deny uncertainty in the data extracted from the medical records. Validation studies should be
conducted with a prospective design. Fourth, our sample population was relatively small.
However, the required number of outcomes was calculated to be 50 when performing multi-
variate logistic analyses using five explanatory variables, and we almost met this threshold.
Fifth, in the present study, given that we did not evaluate the reasons blood was drawn for cul-
ture, we cannot precisely determine the nature of HD patients, particularly feverish patients,
who did not undergo blood culture. However, because clinical judgment on this point is often
impossible to predict, we believe this lack of consideration actually increases the generalizabil-
ity, as stated in the preceding paper, which developed a clinical prediction rule for bacteremia
in the general population. Sixth, cases with undetectable bacteremia (blood culture-negative)
might have existed, which is considered a limitation of blood culture. A new gold standard
method for diagnosing bacteremia is needed. Seventh, this CPR is not strictly a predictor
because it contains “No prior ABx within 1 week”, which increases the positivity of blood cul-
ture. However, we allowed the inclusion of this criterion for the following three reasons: A) If
the CPR had been created only for subjects without prior ABx within 1 week, the discrimina-
tion ability would have been inferior to that of the BAC-HD score (data not shown). B) Since
participants with prior ABx within 1 week were relatively common in the present study (16.4%
in this cohort), their exclusion might have reduced the generalizability. C) Given the possibility
of bacteremia in participants even with prior ABx, careful observation and treatment likely
strongly benefited participants. However, we must recognize the limitations of this score with
respect to the low exclusion accuracy in subjects with BAC-HD score <2 who have used ABx
in the past week and make any clinical judgments carefully. Finally, in the present study, we
were unable to compare the direct discrimination ability between CPRs for the general popula-
tion and the BAC-HD score because of a data shortage. However, unlike the CPR in the gen-
eral population, the BAC-HD score does not include items that greatly vary depending on the
timing of hemodialysis. Therefore, we believe that the validity of the present CPR for HD
patients will likely be higher than CPRs for the general population.
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Conclusion
We developed a simple clinical prediction rule for bacteremia in maintenance HD patients.
We expect that using this rule will facilitate the early detection, early treatment, and improve-
ment of prognosis of bacteremia in HD patients.
Supporting Information
S1 Dataset. The anonymous dataset.
(XLSX)
Acknowledgments
The authors would like to thank Yoshiro Fujita for participating as an external consensus pan-
elist and Digital Medical Communications for the English editing. We also thank the authors
belonging to JOINT-KD for their intellectual support in the management of this study. The
names and affiliations of the authors of the present study belonging to JOINT-KD are Sho
Sasaki (Department of Healthcare Epidemiology, Kyoto University Graduate School of Public
Health, Kyoto), Takeshi Hasegawa (Office for Promoting Medical Research, Showa University,
Tokyo), Hiroo Kawarazaki (Division of Nephrology, Department of Internal Medicine, Inagi
Municipal Hospital, Inagi), Atsushi Nomura (Department of Immunology, Juntendo Univer-
sity School of Medicine, Tokyo), Daisuke Uchida (Department of Nephrology and Hyperten-
sion, Kawasaki Municipal Tama Hospital, Kawasaki), Takahiro Imaizumi (Department of
Nephrology, Toyohashi Municipal Hospital, Toyohashi), Masahide Furusho (Department of
Nephrology, Aso Iizuka Hospital, Iizuka), Hiroki Nishiwaki (Division of Nephrology, Depart-
ment of Medicine, Showa University Fujigaoka Hospital, Yokohama), Yugo Shibagaki (Divi-
sion of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna
University School of Medicine, Kawasaki). The name and contact e-mail of the lead author for
JOINT-KD are Sho Sasaki and ssasaki@fmuac.jp, respectively.
Author Contributions
Conceptualization: SS TH HK YS S. Fukuma.
Data curation: SS HK AN DU TI MF HN.
Formal analysis: SS TH S. Fukuma.
Funding acquisition: SS.
Investigation: SS TH HK S Fukuma YS S. Fukuhara.
Methodology: SS TH HK YS S. Fukuma.
Project administration: SS TH.
Resources: SS HK AN DU TI MF HN.
Software: SS S. Fukuma.
Supervision: SS TH HK S. Fukuma YS S. Fukuhara.
Validation: SS TH.
Visualization: SS TH HK HN S. Fukuma YS.
Writing – original draft: SS TH.
A Clinical Prediction Rule for Bacteremia among Hemodialysis Patients
PLOS ONE | DOI:10.1371/journal.pone.0169975 January 12, 2017 10 / 12
Writing – review & editing: SS TH HK S. Fukuma YS.
References
1. Nielsen SL, Pedersen C, Jensen TG, Gradel KO, Kolmos HJ, Lassen AT. Decreasing incidence rates
of bacteremia: a 9-year population-based study. J Infect 2014; 69(1):51–59. doi: 10.1016/j.jinf.2014.01.
014 PMID: 24576825
2. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk fac-
tors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9(5):869–876. PMID:
9596085
3. Dopirak M, Hill C, Oleksiw M, Dumigan D, Arvai J, English E, et al. Surveillance of hemodialysis-associ-
ated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp
Epidemiol 2002; 23(12):721–724. doi: 10.1086/502000 PMID: 12517013
4. Gilad J, Eskira S, Schlaeffer F, Vorobiov M, Marcovici A, Tovbin D, et al. Surveillance of chronic haemo-
dialysis-associated infections in southern Israel. Clin Microbiol Infect 2005; 11(7):547–552. doi: 10.
1111/j.1469-0691.2005.01168.x PMID: 15966972
5. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis
patients: the USRDS Wave 2 study. Kidney Int 2005; 68(1):311–318. doi: 10.1111/j.1523-1755.2005.
00414.x PMID: 15954922
6. Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, et al. Prevalence and outcomes
of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc
Nephrol 2012; 23(9):1551–1559. doi: 10.1681/ASN.2012010050 PMID: 22904350
7. Fysaraki M, Samonis G, Valachis A, Daphnis E, Karageorgopoulos DE, Falagas ME, et al. Incidence,
clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodi-
alysis. Int J Med Sci 2013; 10(12):1632–1638. doi: 10.7150/ijms.6710 PMID: 24151435
8. Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I. Infections in hemodialysis: a concise
review—Part 1: bacteremia and respiratory infections. Hippokratia 2011; 15(1):12–17. PMID: 21607029
9. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared
with the general population. Kidney Int 2000; 58(4):1758–1764. doi: 10.1111/j.1523-1755.2000.00337.x
PMID: 11012910
10. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis popula-
tion, 1991 to 1999. J Am Soc Nephrol 2004; 15(4):1038–1045. PMID: 15034107
11. Eliakim-Raz N, Bates DW, Leibovici L. Predicting bacteraemia in validated models—a systematic
review. Clin Microbiol Infect 2015; 21(4):295–301. doi: 10.1016/j.cmi.2015.01.023 PMID: 25677625
12. Ratzinger F, Dedeyan M, Rammerstorfer M, Perkmann T, Burgmann H, Makristathis A, et al. A risk pre-
diction model for screening bacteremic patients: a cross sectional study. PLoS One 2014; 9(9):
e106765. doi: 10.1371/journal.pone.0106765 PMID: 25184209
13. van Werkhoven CH, Huijts SM, Postma DF, Oosterheert JJ, Bonten MJ. Predictors of Bacteraemia in
Patients with Suspected Community-Acquired Pneumonia. PLoS One 2015; 10(11):e0143817. doi: 10.
1371/journal.pone.0143817 PMID: 26599636
14. Takeshima T, Yamamoto Y, Noguchi Y, Maki N, Gibo K, Tsugihashi Y, et al. Identifying Patients with
Bacteremia in Community-Hospital Emergency Rooms: A Retrospective Cohort Study. PLoS One
2016; 11(3):e0148078. doi: 10.1371/journal.pone.0148078 PMID: 27023336
15. Lafrance JP, Iqbal S, Lelorier J, Dasgupta K, Ritchie J, Ward L, et al. Vascular access-related blood-
stream infections in First Nations, community and teaching Canadian dialysis units, and other centre-
level predictors. Nephron Clin Pract 2010; 114(3):c204–212. doi: 10.1159/000262303 PMID: 19955826
16. Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB. Difficulty in predicting bacteremia in elderly
emergency patients. Ann Emerg Med 1992; 21(7):842–848. PMID: 1610043
17. Whitelaw DA, Rayner BL, Willcox PA. Community-acquired bacteremia in the elderly: a prospective
study of 121 cases. J Am Geriatr Soc 1992; 40(10):996–1000. PMID: 1401689
18. Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, et al. Blood-
stream infections in the elderly. Am J Med 1989; 86(4):379–384. PMID: 2929625
19. Mylotte JM, McDermott C. Recurrent gram-negative bacteremia. Am J Med 1988; 85(2):159–163.
PMID: 3400692
20. Elhanan G, Raz R, Pitlik SD, Sharir R, Konisberger H, Samra Z, et al. Bacteraemia in a community and
a university hospital. J Antimicrob Chemother 1995; 36(4):681–695. PMID: 8591943
21. Khayr WF, CarMichael MJ, Dubanowich CS, Latif RH. Epidemiology of bacteremia in the geriatric popu-
lation. Am J Ther 2003; 10(2):127–131. PMID: 12629591
A Clinical Prediction Rule for Bacteremia among Hemodialysis Patients
PLOS ONE | DOI:10.1371/journal.pone.0169975 January 12, 2017 11 / 12
22. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia at a Danish university hospital
during a twenty-five-year period (1968–1992). Scand J Infect Dis 1995; 27(3):245–251. PMID: 8539549
23. Girndt M. Bacteraemia in haemodialysis patients—not always Staphylococcus aureus. Nephrol Dial
Transplant 2015; 30(7):1055–1057. doi: 10.1093/ndt/gfv223 PMID: 26056175
24. Vandecasteele SJ, Boelaert JR, De Vriese AS. Staphylococcus aureus infections in hemodialysis: what
a nephrologist should know. Clin J Am Soc Nephrol 2009; 4(8):1388–1400. doi: 10.2215/CJN.
01590309 PMID: 19590063
25. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent
Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explana-
tion and elaboration. Ann Intern Med 2015; 162(1):W1–W73. doi: 10.7326/M14-0698 PMID: 25560730
26. Murray EC, Marek A, Thomson PC, Coia JE. Gram-negative bacteraemia in haemodialysis. Nephrol
Dial Ttransplantation 2015; 30(7):1202–1208.
27. Fram D, Taminato M, Ponzio V, Manfredi SR, Grothe C, Batista RE, et al. Risk factors for morbidity and
mortality of bloodstream infection in patients undergoing hemodialysis: a nested case-control study.
BMC Res Notes 2014; 7:882. doi: 10.1186/1756-0500-7-882 PMID: 25481650
28. Crowley L, Wilson J, Guy R, Pitcher D, Fluck R. Chapter 12 Epidemiology of Staphylococcus aureus
bacteraemia amongst patients receiving dialysis for established renal failure in England in 2009 to
2011: a joint report from the Health Protection Agency and the UK Renal Registry. Nephron Clin Pract
2012; 120 Suppl 1:c233–245.
29. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis
patients: a modifiable risk factor for bacteraemia and death. QJM 2007; 100(7):415–422. doi: 10.1093/
qjmed/hcm040 PMID: 17526532
30. Hosmer DW Jr, Lemeshow S. Applied logistic regression: John Wiley & Sons; 2004.
31. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the perfor-
mance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21
(1):128–138. doi: 10.1097/EDE.0b013e3181c30fb2 PMID: 20010215
32. Efron B. Bootstrap methods: another look at the jackknife: Springer; 1992.
33. Saxena AK, Panhotra BR, Al-Mulhim AS. Vascular access related infections in hemodialysis patients.
Saudi J Kidney Dis Transpl 2005; 16(1):46–71. PMID: 18209459
34. Katneni R, Hedayati SS. Central venous catheter-related bacteremia in chronic hemodialysis patients:
epidemiology and evidence-based management. Nat Clin Pract Nephrol 2007; 3(5):256–266. doi: 10.
1038/ncpneph0447 PMID: 17457359
35. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, et al. Facility hemodialysis vascular
access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J
Kidney Dis 2009; 53(3):475–491. doi: 10.1053/j.ajkd.2008.10.043 PMID: 19150158
36. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and
outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.
Nephrol Dial Transplantation 2008; 23(10):3219–3226.
37. Tung CB, Tung CF, Yang DY, Hu WH, Hung DZ, Peng YC, et al. Extremely high levels of alkaline phos-
phatase in adult patients as a manifestation of bacteremia. Hepato-gastroenterology 2005; 52(65):1347–
1350. PMID: 16201071
38. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420(6917):885–981. doi: 10.1038/
nature01326 PMID: 12490963
39. Peters E, Heemskerk S, Masereeuw R, Pickkers P. Alkaline phosphatase: a possible treatment for sep-
sis-associated acute kidney injury in critically ill patients. Am J Kidney Dis 2014; 63(6):1038–1048. doi:
10.1053/j.ajkd.2013.11.027 PMID: 24462020
40. Peters E, van Elsas A, Heemskerk S, Jonk L, van der Hoeven J, Arend J, et al. Alkaline phosphatase as
a treatment of sepsis-associated acute kidney injury. J Pharmacol Exp Ther 2013; 344(1):2–7. doi: 10.
1124/jpet.112.198226 PMID: 23131595
A Clinical Prediction Rule for Bacteremia among Hemodialysis Patients
PLOS ONE | DOI:10.1371/journal.pone.0169975 January 12, 2017 12 / 12
